Nervous About Stagflation? Buy These 2 Growth Stocks
It's harder for stagflation to hurt a company's bottom line when costs don't change much.
The Company is engaged principally in the ownership, operation, management, selective redevelopment, development and acquisition of properties for the life sciences industry.
| Symbol | Last Price | Market Cap | % Δ 1 Yr | % Δ 5 Yr |
|---|---|---|---|---|
|
ARE
Alexandria Real Estate Equities
|
$188.43 | $30B | 19.1% | 98.1% |
|
AMT |
$234.84 | $107B | 12.0% | 126.6% |
|
CCI |
$173.63 | $75B | 14.8% | 127.8% |
|
EQIX |
$693.55 | $63B | 7.6% | 99.7% |
|
HHC |
$95.42 | $5B | -2.0% | -18.4% |
It's harder for stagflation to hurt a company's bottom line when costs don't change much.
The real estate investment trust's founder thinks we are seeing the "industrial revolution" in biotech.
They're both better at providing cash flow than an index fund.
Here's a trio of REITs that can rise with this tide and whatever's next.
Alexandria Real Estate Equities and Duke Realty are reliable choices for long-term gain.
Its head start is quite encouraging.
Leadership in lab and legal marijuana properties mark these two as 2022 winners.
Is biotech the next industrial revolution? This company thinks so.
These leaders in life sciences and medical marijuana spaces look good now and going forward.
ARE earnings call for the period ending September 30, 2021.